Clinuvel soars on UV drug results announcement to ASX
SYDNEY: Shares in Clinuvel Pharma are up 15 per cent to $17.48 at 2pm AEST
SYDNEY: Shares in Clinuvel Pharma are up 15 per cent to $17.48 at 2pm AEST
FEATURED
101-storey tower has been approved Boomer market
Government overrides planning niceties to fast track Regen site projects
Best social housing community design for Global Awards shortlisted
Developer rolls out affordable housing for seniors and low-income residents
Loneliness has deeper impact on mental health than financial hardship
Country set to launch first-ever rental social housing campaign
INNOVATION
